| Clinical practice guidelines for hepatocellular carcinom... |
46 |
| Impact of sodium glucose cotransporter 2 inhibitor on hi... |
26 |
| Therapeutic potential of lenvatinib for unresectable hep... |
24 |
| Immune checkpoint blockade for the treatment of human he... |
20 |
| Effect of luseogliflozin on hepatic fat content in type ... |
18 |
| Recent advances in medical management of hepatocellular ... |
17 |
| Glecaprevir and pibrentasvir for Japanese patients with ... |
17 |
| Phase 3 drug pipelines in the treatment of non-alcoholic... |
17 |
| Efficacy and safety of edoxaban for treatment of portal ... |
16 |
| Clinical outcomes of sorafenib treatment failure for adv... |
16 |
